Hookipa Pharma Rg

Hookipa Pharma is a clinical‑stage biotech harnessing its proprietary arenavirus platform to develop immunotherapies for KRAS‑mutated cancers, HPV⁺ head & neck cancers, HBV, and HIV, with Phase I–II trials and a Gilead partnership.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Professional Services
Industry: Biotechnology Research

Employees: 82
HQ: New York

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
HOOK	Hookipa Pharma Rg Cap: 0.0B	EQUITY	NMS	USD	US43906K1007	Active	📈